Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,027 | 150 | 94.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $113.16 | 1 | 5.3% |
| Education | $13.89 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $332.70 | 19 | $0 (2017) |
| Lilly USA, LLC | $252.68 | 25 | $0 (2017) |
| PFIZER INC. | $237.48 | 23 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $206.54 | 17 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $192.04 | 8 | $0 (2017) |
| Indivior Inc. | $173.67 | 5 | $0 (2017) |
| GlaxoSmithKline, LLC. | $172.61 | 12 | $0 (2017) |
| Amgen Inc. | $163.03 | 11 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $109.91 | 8 | $0 (2017) |
| Novo Nordisk Inc | $108.13 | 10 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $2,154 | 152 | Boehringer Ingelheim Pharmaceuticals, Inc. ($332.70) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/09/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2017 | PFIZER INC. | VIAGRA (Drug), CHANTIX, ELIQUIS | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 11/06/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: DIABETES | ||||||
| 10/27/2017 | PFIZER INC. | CHANTIX (Drug), LYRICA | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/23/2017 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Diabetes | ||||||
| 10/23/2017 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $2.47 | General |
| Category: Diabetes | ||||||
| 10/20/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Diabetes | ||||||
| 10/20/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: Diabetes | ||||||
| 10/18/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Diabetes | ||||||
| 10/18/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: Obesity | ||||||
| 10/18/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Endocrinology | ||||||
| 10/10/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: DIABETES | ||||||
| 10/05/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/04/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/28/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Urology | ||||||
| 09/26/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $0.48 | General |
| Category: DIABETES | ||||||
| 09/19/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: DIABETES | ||||||
| 09/19/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: DIABETES | ||||||
| 09/18/2017 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 249 | 268 | $50,291 | $14,887 |
| 2022 | 6 | 195 | 204 | $43,356 | $14,750 |
| 2021 | 8 | 296 | 302 | $52,649 | $19,128 |
| 2020 | 9 | 283 | 286 | $52,403 | $16,503 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 83 | $18,930 | $5,009 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 35 | $11,025 | $3,248 | 29.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $9,800 | $2,987 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,670 | $2,287 | 40.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 17 | 17 | $1,700 | $588.54 | 34.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 13 | 26 | $676.00 | $421.72 | 62.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 12 | 12 | $720.00 | $194.40 | 27.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 13 | 13 | $1,560 | $105.04 | 6.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 20 | 21 | $210.00 | $46.20 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 81 | $17,566 | $5,877 | 33.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 48 | 48 | $10,495 | $3,885 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 26 | $8,085 | $2,892 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,405 | $1,529 | 44.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 23 | 24 | $3,680 | $535.53 | 14.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 14 | $125.00 | $31.07 | 24.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 78 | 78 | $16,146 | $7,024 | 43.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 89 | $18,423 | $6,173 | 33.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 15 | $4,400 | $1,528 | 34.7% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 19 | 19 | $2,850 | $1,358 | 47.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 21 | 22 | $3,300 | $1,211 | 36.7% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 25 | 25 | $2,500 | $1,035 | 41.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 31 | 34 | $4,930 | $754.80 | 15.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 20 | 20 | $100.00 | $45.00 | 45.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 50 | 50 | $15,000 | $5,559 | 37.1% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 39 | 39 | $5,850 | $2,896 | 49.5% |
About Dr. Stephen Murak, MD
Dr. Stephen Murak, MD is a Family Medicine healthcare provider based in Lewiston, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2011. The National Provider Identifier (NPI) number assigned to this provider is 1851685572.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Murak, MD has received a total of $2,154 in payments from pharmaceutical and medical device companies, with $2,154 received in 2017. These payments were reported across 152 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,027).
As a Medicare-enrolled provider, Murak has provided services to 1,023 Medicare beneficiaries, totaling 1,060 services with total Medicare billing of $65,268. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Emergency Medicine
- Location Lewiston, NY
- Active Since 05/31/2011
- Last Updated 02/01/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851685572
Products in Payments
- JARDIANCE (Drug) $329.05
- SUBOXONE SUBLINGUAL FILM (Drug) $173.67
- Prolia (Biological) $163.03
- TRULICITY (Drug) $135.51
- FARXIGA (Drug) $124.91
- JANUVIA (Drug) $115.37
- ANORO (Drug) $89.96
- VIAGRA (Drug) $89.02
- STIOLTO (Drug) $73.83
- ASMANEX (Drug) $71.22
- Myrbetriq (Drug) $64.47
- Victoza (Drug) $64.27
- XARELTO (Drug) $58.69
- CHANTIX (Drug) $57.78
- BEVESPI AEROSPHERE (Drug) $51.42
- TOUJEO (Drug) $47.60
- BREO (Drug) $41.33
- ADVAIR (Drug) $41.32
- LYRICA (Drug) $41.10
- PRALUENT (Drug) $38.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lewiston
Dr. Jeffrey Michaud, Do, DO
Family Medicine — Payments: $5,950
Dr. Robert Bull, Md, MD
Family Medicine — Payments: $5,628
Dr. Albert Hartman, Md, MD
Family Medicine — Payments: $3,181
Celso Chavez, Md, MD
Family Medicine — Payments: $2,776
Dr. Donald Greggain, M.d, M.D
Family Medicine — Payments: $2,587
Mina Assadollahzadeh, Do, DO
Family Medicine — Payments: $1,627